Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elsayed G E, Elsakka"'
Autor:
Ibrahim F. Nassar, Mohammed T. Abdel Aal, Wael A. El-Sayed, Mahmoud A. E Shahin, Elsayed G. E. Elsakka, Mahmoud Mohamed Mokhtar, Maghawry Hegazy, Mohamed Hagras, Asmaa A. Mandour, Nasser S. M. Ismail
Publikováno v:
RSC Advances. 12:14865-14882
A new set of pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffolds (4–13) as well as the thioglycoside derivatives (14, 15) were designed, and synthesized as novel CDK2 targeting compounds.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86aedb589d457e6681787883111dcde3
https://doi.org/10.1039/d2ra01968j
https://doi.org/10.1039/d2ra01968j
Autor:
Ibrahim F, Nassar, Mohammed T, Abdel Aal, Wael A, El-Sayed, Mahmoud, A E Shahin, Elsayed G E, Elsakka, Mahmoud Mohamed, Mokhtar, Maghawry, Hegazy, Mohamed, Hagras, Asmaa A, Mandour, Nasser S M, Ismail
Publikováno v:
RSC advances. 12(23)
CDK2 inhibition is an appealing target for cancer treatment that targets tumor cells in a selective manner. A new set of small molecules featuring the privileged pyrazolo[3,4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::200c80895d1cf7b677a0bd0e9735705f
https://pubmed.ncbi.nlm.nih.gov/35702208
https://pubmed.ncbi.nlm.nih.gov/35702208